↓ Skip to main content

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

Overview of attention for article published in The Lancet, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

blogs
1 blog
f1000
1 research highlight platform

Citations

dimensions_citation
306 Dimensions

Readers on

mendeley
213 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
Published in
The Lancet, May 2011
DOI 10.1016/s0140-6736(11)60394-2
Pubmed ID
Authors

Jill Belch, William R Hiatt, Iris Baumgartner, I Vickie Driver, Sigrid Nikol, Lars Norgren, Eric Van Belle, on behalf of the TAMARIS Committees and Investigators

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 213 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Colombia 1 <1%
Brazil 1 <1%
France 1 <1%
Russia 1 <1%
Ukraine 1 <1%
Unknown 206 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 15%
Student > Ph. D. Student 27 13%
Student > Master 24 11%
Student > Bachelor 18 8%
Professor > Associate Professor 15 7%
Other 51 24%
Unknown 47 22%
Readers by discipline Count As %
Medicine and Dentistry 66 31%
Biochemistry, Genetics and Molecular Biology 25 12%
Agricultural and Biological Sciences 22 10%
Nursing and Health Professions 18 8%
Engineering 7 3%
Other 21 10%
Unknown 54 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2011.
All research outputs
#5,587,283
of 26,017,215 outputs
Outputs from The Lancet
#20,963
of 43,155 outputs
Outputs of similar age
#27,850
of 127,206 outputs
Outputs of similar age from The Lancet
#182
of 408 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,155 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,206 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 408 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.